Jia-hua Feng

Mr. Jia-hua Feng

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JFJia-hua Feng
Jia-hua Feng
KCKang Chen
Kang Chen
SSSi-Yu Shen
Si-Yu Shen
YLYun-Feng Luo
Yun-Feng Luo
XLXi-Hong Liu
Xi-Hong Liu
YTYuru Tong
Yuru Tong
Corydalis yanhusuo W. T. Wang, also known as yanhusuo, yuanhu, yanhu and xuanhu, is one of the herb components of many Chinese Traditional Medicine prescriptions such as Jin Ling Zi San and Yuanhu-Zhitong priscription. C. yanhusuo was traditionally used to relieve pain and motivate blood and Qi circulation. Now there has been growing interest in pharmacological effects of alkaloids, the main bioactive components of C. yanhusuo. Eighty-four alkaloids isolated from C. yanhusuo are its important bioactive components and can be characterized into protoberberine alkaloids, aporphine alkaloids, opiate alkaloids and others and proper extraction or co-administration methods modulate their contents and efficacy. Alkaloids from C. yanhusuo have various pharmacological effects on the nervous system, cardiovascular system, cancer and others through multiple molecular mechanisms such as modulating neurotransmitters, ion channels, gut microbiota, HPA axis and signaling pathways and are potential treatments for many diseases. Plenty of novel drug delivery methods such as autologous red blood cells, self-microemulsifying drug delivery systems, nanoparticles and others have also been investigated to better exert the effects of alkaloids from C. yanhusuo. This review summarized the alkaloid components of C. yanhusuo, their pharmacological effects and mechanisms, and methods of drug delivery to lay a foundation for future investigations.

1 November 2021
Verified
Journal Article
Closed access
YLYun-Feng Luo
Yun-Feng Luo
KLKe-Yi Liu
Ke-Yi Liu
JFJia-hua Feng
Jia-hua Feng
YTYu-Ru Tong
Yu-Ru Tong
WGWei Gao
Wei Gao

6 November 2026 in Medicine
Verified
Journal Article
Open access
LGLianpeng Guan
Lianpeng Guan
FDFangfang Duan
Fangfang Duan
CQChuandong Qin
Chuandong Qin
WWWenkai Wu
Wenkai Wu
GYGuihe Yang
Guihe Yang
YLYAJUN LIU
YAJUN LIU
Background: Sarcopenia, characterized by the progressive loss of skeletal muscle mass, strength, and function, poses a significant health challenge in aging populations. Early identification through effective screening tools is critical to mitigate risks such as falls, fractures, and frailty. This study aimed to analyze global research trends in sarcopenia screening tools using bibliometric methods to identify key contributors and emerging hotspots, thereby guiding future research directions. Methods: Data were retrieved from the Web of Science Core Collection (WoSCC) for the period from January 2013 to March 2025. A total of 180 articles were analyzed using bibliometric tools such as the R package bibliometrix, VOSviewer, and CiteSpace. The analysis focused on publication trends, citation impact, co-authorship networks, and keyword co-occurrence to map research trends and identify influential studies and screening tools. Results: The analysis revealed a steady increase in research output since 2013, with an annual growth rate of 38.16%. China emerged as the leading contributor, accounting for 30% of publications, followed by Japan and Brazil. Among the screening tools investigated, the Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire was the most studied tool, followed by SARC-F combined with calf circumference (SARC-CalF) and calf circumference measurements. Citation analysis highlighted pivotal studies on SARC-F validation, while emerging hotspots included tools like the Mini Sarcopenia Risk Assessment (MSRA) and Ishii test, reflecting a shift toward more practical and accessible screening methods. Conclusion: This bibliometric analysis maps global advancements in sarcopenia screening tools, highlighting China’s prolific research output (30% of publications) and the development of culturally adapted instruments in Japan (Ishii test, Yubi-wakka method). The SARC-F questionnaire dominates research focus, spurring innovations including SARC-CalF and calf circumference metrics. The findings advocate standardized validation frameworks and integration of evidence-based screening into geriatric care policies, emphasizing tool accessibility and clinical utility to combat sarcopenia in aging populations.

19 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
QRQuanzhong Ren
Quanzhong Ren
GYGuihe Yang
Guihe Yang
DWDingding Wang
Dingding Wang
WWWenkai Wu
Wenkai Wu
YWYi Wang
Yi Wang
RWRenxian Wang
Renxian Wang
Abnormal iron metabolism is closely linked to sarcopenia; however, the specific iron metabolism features of fat-infiltrating sarcopenia remain poorly understood. Proteomic sequencing revealed that in skeletal muscle with severe fat infiltration, the expression of iron utilization-related proteins was significantly downregulated, whereas that of iron uptake and storage proteins was markedly upregulated, thereby presenting an abnormal iron deficiency (ID) phenotype. Nevertheless, the mechanism by which ID drives intramuscular fat infiltration has not been fully elucidated. Using clinical samples, aged murine ID models, and in vitro cell assays, this study is the first to demonstrate that ID stabilizes hypoxia-inducible factor-1α (HIF-1α), promoting aberrant adipogenic differentiation of fibro-adipogenic progenitors (FAPs), disrupting the homeostatic balance between satellite cells (SCs) and FAPs, exacerbating skeletal muscle fat infiltration, and impairing muscle repair capacity. Notably, treatment with the HIF-1α inhibitor PX478 reversed these pathological alterations and improved muscle function. Collectively, our findings identify the ID-HIF-1α-FAPs axis as a key driver of intramuscular fat infiltration, offering a novel therapeutic target for the clinical management of fat-infiltrating sarcopenia.